Publication | Closed Access

Protection against post-ischemic behavioral pathology by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil

Molecular Pharmacologyα-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidMedicineBehavioural PharmacologyBehavioral PharmacologyPsychopharmacologyNeuropharmacologyExperimental PharmacologyPharmacotherapyPost-ischemic Behavioral PathologyPharmacologyDrug Discovery